SALVETTI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 1.635
EU - Europa 898
AS - Asia 801
SA - Sud America 76
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.435
Nazione #
US - Stati Uniti d'America 1.611
SG - Singapore 393
CN - Cina 275
IT - Italia 183
DE - Germania 150
IE - Irlanda 98
SE - Svezia 93
FI - Finlandia 87
AT - Austria 62
BR - Brasile 59
DK - Danimarca 50
FR - Francia 45
UA - Ucraina 45
VN - Vietnam 41
HK - Hong Kong 24
IN - India 22
GB - Regno Unito 18
BE - Belgio 13
BY - Bielorussia 13
CA - Canada 13
AR - Argentina 12
CH - Svizzera 11
MX - Messico 9
KR - Corea 7
NL - Olanda 7
RU - Federazione Russa 7
ZA - Sudafrica 7
ID - Indonesia 6
SN - Senegal 6
BD - Bangladesh 5
ES - Italia 5
PL - Polonia 4
TH - Thailandia 4
JP - Giappone 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
CO - Colombia 2
EG - Egitto 2
EU - Europa 2
IQ - Iraq 2
LT - Lituania 2
MA - Marocco 2
RO - Romania 2
TR - Turchia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
YE - Yemen 2
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
EC - Ecuador 1
GR - Grecia 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
ML - Mali 1
MW - Malawi 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
TG - Togo 1
TN - Tunisia 1
VE - Venezuela 1
Totale 3.435
Città #
Chandler 300
Singapore 217
Santa Clara 157
Beijing 150
Munich 102
Dublin 98
Ashburn 93
Ann Arbor 89
Helsinki 66
Vienna 58
Dearborn 51
Nyköping 49
Torino 48
Wilmington 44
Fairfield 41
Dallas 35
Medford 34
Houston 32
Jacksonville 32
Los Angeles 29
Columbus 27
Princeton 27
Turin 27
Woodbridge 27
Fremont 22
Seattle 20
Hong Kong 19
San Mateo 18
Guangzhou 17
Cambridge 15
Brussels 13
Hangzhou 13
Dong Ket 12
New York 12
Chennai 10
Hanoi 10
Redwood City 10
Linden 9
São Paulo 9
Buffalo 8
Chengdu 8
Hefei 8
Jyväskylä 8
Oerlikon 8
Falkenstein 7
Turku 7
Codogno 6
Falls Church 6
Ho Chi Minh City 6
Redondo Beach 6
San Diego 6
San Jose 6
Seoul 6
Wayne 6
Belo Horizonte 5
Casorzo 5
Central District 5
Guiyang 5
Indianapolis 5
Nanjing 5
Villeurbanne 5
Canelli 4
Cape Town 4
Denver 4
Duncan 4
Jakarta 4
Mexico City 4
Milan 4
Norwalk 4
Piemonte 4
Rome 4
Shanghai 4
Toronto 4
Atlanta 3
Balingen 3
Biên Hòa 3
Changsha 3
Chicago 3
Chieri 3
Council Bluffs 3
Erlangen 3
Hyderabad 3
Johannesburg 3
Lappeenranta 3
Leawood 3
London 3
Montreal 3
Mortara 3
Nuremberg 3
Ottawa 3
Varese 3
Washington 3
Wuhan 3
Amsterdam 2
Bologna 2
Brasília 2
Cologne 2
Düsseldorf 2
Florence 2
Haiphong 2
Totale 2.301
Nome #
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET 331
Regulation of HIF-1α in TP53 disrupted chronic lymphocytic leukemia cells and its potential role as a therapeutic target 224
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia 197
Magic pills: new oral drugs to treat chronic lymphocytic leukemia 174
Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs 165
Regulation of HIF-1α in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role as a Therapeutic Target 142
Selinexor in Combination with Chemotherapy or Idelalisib Elicits a Synergistic Cytotoxic Effect in Primary CLL Cells, Also Overcoming Intrinsic and Stromal Cells-Mediated Fludarabine Resistance 139
Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 139
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems 132
Idelalisib nei pazienti con leucemia linfatica cronica e linfoma follicolare: esperienza monocentrica real life 130
Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib 127
SELINEXOR (KPT-330) IN COMBINATION WITH CHEMOTHERAPY OR IDELALISIB ELICITS A SYNERGISTIC CYTOTOXIC EFFECT IN PRIMARY CLL CELLS, ALSO OVERCOMING INTRINSIC AND STROMAL CELLS-MEDIATED FLUDARABINE RESISTANCE 124
Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia 119
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia 118
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells 118
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll 113
Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs 106
Regulation of HIF-1α in TP53 disrupted chronic lymphocytic leukemia cells and its potential role as a therapeutic target 105
Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells 104
TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 99
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection 98
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia 96
TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 88
TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 88
Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantation 84
Selinexor in Combination with Chemotherapy or Idelalisib Elicits a Synergistic Cytotoxic Effect in Primary CLL Cells 72
Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights 70
Totale 3.502
Categoria #
all - tutte 11.001
article - articoli 0
book - libri 0
conference - conferenze 6.985
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.986


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021315 0 0 0 0 71 33 29 40 32 20 55 35
2021/2022402 23 8 19 24 30 8 31 19 11 30 119 80
2022/2023615 70 71 28 63 54 137 34 41 58 25 22 12
2023/2024174 26 39 7 10 7 29 5 6 4 12 9 20
2024/2025835 1 5 32 68 219 89 80 74 114 29 42 82
2025/2026503 117 51 81 132 122 0 0 0 0 0 0 0
Totale 3.502